ROTH Capital raised the price target for the Ampio Pharmaceuticals Inc. (AMEX:AMPE) stock to “a Buy”. The rating was released on December 19, 2019. We previously noted in another research note published on March 17, 2014 by Aegis Capital that reiterated the stock to a Buy with a price target of $16 for AMPE stock. The research report from Aegis Capital has initiated the stock to Buy, with a price target set at $11.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Ampio Pharmaceuticals Inc. (AMEX:AMPE) dipped 0.00% to close Friday’s market session at $1.62, lower as compared to yesterday’s close. The stock price fluctuated between $1.60 and $1.65 throughout the trading session with the volume trading being 703803 shares, which represented a significant variation when compared to the three months average volume of 2.04 million shares. The firm’s stock price fluctuated -4.14% within the last five trades and -10.00% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 10.96% in the last 6 months and -10.99% was subtracted to its value over the previous 3 months. AMPE stock is trading at a margin of -7.48%, -10.02% and 7.15% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, AMPE deals in the Healthcare domain. The stock is trading -45.64 percent below its 52-week high and 160.91 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -1.46. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Ampio Pharmaceuticals Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
The stock’s market cap achieved a total value of $328.67 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The firm managed a Price-to-Book ratio of 18.00, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.40 percent of Ampio Pharmaceuticals Inc. shares are owned by insiders, and 17.80 percent are held by financial institutions. STOKELY DAN, the CFO at Ampio Pharmaceuticals Inc. (AMPE) has sold 22,500 shares of firm on Jun 25 at a price of $1.79 against the total amount of $40275.0. In another inside trade, COELHO PHILIP H, Director of Ampio Pharmaceuticals Inc. (AMEX:AMPE) sold 6,737 shares of the firm on May 21 for a total worth of $13474.0 at a price of $2.00. An inside trade which took place on May 21, CHIEF OPERATING OFFICER of Ampio Pharmaceuticals Inc. Cherevka Holli sold 2,603 shares of firm against total price of $5206.0 at the cost of $2.00 per share.